Sagimet Biosciences issues pre-funded warrants in $10.00-per-share offering
SGMT•Sagimet Biosciences agreed to sell 8,750,010 common shares at $10.00 each and pre-funded warrants for up to 2,750,010 shares at $9.9999 each. The offering is expected to close Oct. 1, 2026, with net proceeds estimated at $107.5 million.
1. Offering details
The pre-funded warrants have an exercise price of $0.0001 per share and are immediately exercisable. Exercises are limited to 4.99% beneficial ownership, or 9.99% at the holder’s election; the limit can be increased to 19.99% with 61 days’ notice.
